two monoclonal anti-ldl-apo b antibodies ( 464b1b3 and 464b1b6 , 2a and 2b , respectively ) and two anti-apo e antibodies ( 1506 a1.4 and 1907 f6.4 ) were used to inhibit lipoprotein-cell interactions .
C0003595
apo e
C0023820
lipoprotein